scholarly article | Q13442814 |
P50 | author | Jih-Hwa Guh | Q40601635 |
P2093 | author name string | C M Teng | |
S C Chueh | |||
F N Ko | |||
P2860 | cites work | A Placebo-controlled Double-blind Study of the Effect of Phenoxybenzamine in Benign Prostatic Obstruction | Q28295255 |
Some quantitative uses of drug antagonists | Q29616831 | ||
Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5 | Q33261641 | ||
Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor | Q33650916 | ||
Pharmacologic characterization of cloned alpha 1-adrenoceptor subtypes: selective antagonists suggest the existence of a fourth subtype | Q34245118 | ||
Calcium channel antagonists: pharmacological considerations | Q34446580 | ||
Alpha- and beta-adrenoceptors in hypertension: molecular biology and pharmacological studies | Q35263438 | ||
Clinical experience with alpha-adrenoceptor antagonists in benign prostatic hypertrophy | Q38167097 | ||
How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated? | Q39196960 | ||
Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. | Q39323686 | ||
Classification of phenoxybenzamine/prazosin-resistant contractions of rat spleen to norepinephrine by Schild analysis: similarities and differences to postsynaptic alpha-2 adrenoceptors | Q41333324 | ||
Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens | Q41841488 | ||
Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen | Q41868143 | ||
Ontogenic increase in PGE2 and PGF2 alpha receptor density in brain microvessels of pigs | Q42700906 | ||
Selective irreversible binding of chloroethylclonidine at alpha 1- and alpha 2-adrenoceptor subtypes | Q42804160 | ||
Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists | Q42847779 | ||
In vitro characterization of the alpha-adrenoceptors in human prostate | Q43843788 | ||
Pharmacological characteristics of smooth muscle in benign prostatic hyperplasia and normal prostatic tissue | Q44666583 | ||
Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle | Q48205465 | ||
The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity | Q48636917 | ||
Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in the hyperplastic human prostate. | Q52245597 | ||
Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate. | Q53717535 | ||
Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101. | Q54333560 | ||
Prazosin in the Treatment of Prostatic Obstruction A Placebo-controlled Study | Q61614985 | ||
Species heterogeneity of hepatic alpha 1-adrenoceptors: alpha 1A-, alpha 1B- and alpha 1C-subtypes | Q67540916 | ||
Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF Group | Q67691450 | ||
Subtypes of alpha 1-adrenoceptors in rat blood vessels | Q68076806 | ||
Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy | Q68999764 | ||
5-Methyl-urapidil discriminates between subtypes of the alpha 1-adrenoceptor | Q69924455 | ||
Autonomic innervation of the human prostate | Q71129463 | ||
Alpha 1 adrenoceptor subtypes in the human prostate | Q72211259 | ||
The alpha-adrenergic blocking effect of prazosin on the human prostate | Q72490944 | ||
Characterization of alpha 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man | Q72664424 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 142-146 | |
P577 | publication date | 1995-05-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Characterization of alpha 1-adrenoceptor subtypes in tension response of human prostate to electrical field stimulation | |
P478 | volume | 115 |
Q27027373 | Age-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progression |
Q34445169 | Alpha-adrenergic approach in the medical management of benign prostatic hyperplasia |
Q34334931 | Alpha-blockers and lower urinary tract function: more than smooth muscle relaxation? |
Q35545711 | Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate |
Q36094341 | Alpha1-adrenoceptors are required for normal male sexual function |
Q42728606 | Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery |
Q42116193 | Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig. |
Q74579014 | Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate |
Q46236880 | Cardiovascular/Pulmonary Medications and Male Reproduction |
Q44028373 | Characterization of some novel alpha 1-adrenoceptor antagonists in human hyperplastic prostate |
Q37556280 | Clinical and experimental aspects of Adreno-muscarinic synergy in the bladder base and prostate |
Q49136437 | Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate |
Q44193393 | Enhancement of alpha-adrenoceptor-mediated responses in prostate of testosterone-treated rat. |
Q45185263 | Evaluation of the mouse prostate as a suitable model for the study of human prostate function |
Q28369721 | Investigation of the effects of some alkaloidal alpha1-adrenoceptor antagonists on human hyperplastic prostate |
Q46825282 | Noradrenergic vasoconstriction of pig prostatic small arteries |
Q35089850 | Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH). |
Q35873635 | Ouabain-induced increases in resting tone of human hyperplastic prostate following repeated noradrenaline and electrical field stimulation. |
Q41448071 | Prostatic alpha 1-adrenoceptors and uroselectivity |
Q46815533 | Protein kinase G-induced activation of K(ATP) channels reduces contractility of human prostate tissue |
Q51544359 | Recent advances in the identification of alpha1- and alpha2-adrenoceptor subtypes: therapeutic implications. |
Q34190626 | The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies |
Q41780955 | The effects of SB 216469, an antagonist which discriminates between the alpha 1A-adrenoceptor and the human prostatic alpha 1-adrenoceptor. |
Q73302741 | alpha(1L)-adrenoceptors mediate noradrenaline-induced contractions of the guinea-pig prostate stroma |